ALEXANDRIA, Va., June 6 -- United States Patent no. 12,280,023, issued on April 22, was assigned to ATROGI AB (Solna, Sweden).
"Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia" was invented by Benjamin Pelcman (Stockholm) and Tore Bengtsson (Vaxholm, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "There is herein provided a compound of formula (I)."
The patent was filed on April 11, 2023, under Application No. 18/133,060.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12280023&OS=12280023&RS=1228...